NAV
₹598.2473
as of 29 Sept 2026
Expense Ratio
1.03%
Lumpsum returns (CAGR)
- 1Y
- +24.32%
- 3Y
- +23.78%
- 5Y
- +18.43%
- Since Inception
- +18.19%
SIP returns (XIRR)
- 1Y
- +29.74%
- 3Y
- +20.34%
- 5Y
- +22.69%
- Since Inception
- +17.89%
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Pharmaceuticals & Biotechnology62.04%
- Healthcare Services27.64%
- Chemicals & Petrochemicals5.17%
- Healthcare Equipment & Supplies1.94%
Each sector links to the mutual funds most exposed to it.
Thinking about SBI Healthcare Opportunities Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH
- 1Sun Pharmaceutical Industries Ltd.12.33%
- 2Divi'S Laboratories Ltd.8.17%
- 3Apollo Hospitals Enterprise Ltd.4.91%
- 4Acutaas Chemicals Ltd.4.91%
- 5Torrent Pharmaceuticals Ltd.4.72%
- 6Cipla Ltd.4.67%
- 7Max Healthcare Institute Ltd.4.31%
- 8Laurus Labs Ltd.3.96%
- 9Aurobindo Pharma Ltd.3.90%
- 10Aster Dm Quality Care Ltd.3.52%
What this fund does
SBI Healthcare Opportunities Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
SBI Healthcare Opportunities Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by SBI Mutual Fund. The fund has been operational for over 13 years. The current expense ratio is 1.03%.